Biological Analyses for Characterization of the Uterine Sarcoma Using Mouse Model
Journal Title: Journal of Gynecological Research and Obstetrics - Year 2015, Vol 3, Issue 3
Abstract
Uterine sarcomas are neoplastic malignancies that typically arise in tissues of a mesenchymal origin in uterine body. The identification of novel molecular mechanisms leading to sarcoma formation, and the establishment of new therapies and biomarkers has been hampered by several critical factors. Uterine leiomyosarcoma (U-LMS), which is the most common sarcoma, is rarely observed in clinical settings, with fewer than 15,000 new cases being diagnosed each year in the United States. Another complicating factor is that U-LMS are extremely heterogeneous as they arise in a multitude of tissues from many different cell lineages. The scarcity of clinical samples coupled with its inherent heterogeneity creates a challenging experimental environment for clinicians and scientists. Faced with these challenges, there have been extremely limited advances in treatment options available to patients with U-LMS compared with those for patients with other malignant tumors. In order to glean insight into the pathobiology of U-LMS, scientists are now using mouse models whose genomes have been specifically tailored to carry gene deletions, gene amplifications, and point mutations commonly observed in human soft tissue sarcomas. The use of these model organisms has been successful in increasing our knowledge and understanding of how alterations in relevant oncogenic, tumor suppressive, and signaling pathways directly impact sarcomagenesis. It is the aim of many in the biological community that the use of these genetically modified mouse models will serve as powerful in vivo tools to further our understanding of sarcomagenesis and potentially identify novel biomarkers and develop therapeutic strategies.
Authors and Affiliations
Hayashi Takuma, Ichimura Tomoyuki, Kasai Mari, Kanai Yae, Ando Hirofumi, Ida Koichi, Yaegashi Nobuo, Tonegawa Susumu, Konishi Ikuo
Keywords
Related Articles
- EP ID EP337321
- DOI 10.17352/jgro.000040
- Views 89
- Downloads 0
Woman as a gynecological patient
Health is a state of complete physical, mental and social well-being, and not just freedom from disease or disability is definition of the World Health Organization means that the quality of health care must not only ind...
Case Report: Pelvic abscess formation secondary to the use of commercial hemostatic topical agent in an immunocompromised patient?
Various hemostatic agents are currently available for routine laparoscopic procedures, avoiding thermal lesions due to energy devices and the complexity of intracorporeal sutures, however, evidence of complications in im...
Lack of Association between the 4234G/C X-Ray Repair Cross-Complementing 2 (XRCC2) Gene Polymorphism and the Risk of Endometrial Cancer among Polish Population
Objective: One of the major causes of carcinogenesis is loss of genome stability. The double-strand break DNA repair pathway, including X-ray repair cross complementing group 2 (XRCC2) gene, is implicated in maintenance...
Ovarian Hyperstimulation Syndrome in Spontaneous Pregnancy
Background: Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of supraphysiologic ovarian stimulation but infrequently has been described in spontaneous pregnancy. Aim: To present a case of a woman...
Follicular Variant of Papillary Thyroid Carcinoma Arising in a Mature Cystic Teratoma of the Ovary
Mature cystic teratomas form approximately 20% of all ovarian tumours. Of these, approximately 15% include benign thyroid tissue. When thyroid tissue comprises more than 50% of the ovarian teratoma, it is termed ‘‘struma...